Authors:
Tesch, GH
Hill, PA
Wei, M
Nikolic-Paterson, DJ
Dutartre, P
Atkins, RC
Citation: Gh. Tesch et al., LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease, KIDNEY INT, 60(4), 2001, pp. 1354-1365
Authors:
Ducoroy, P
de Fornel, D
Chirade, F
Fontet, P
Dutartre, P
Citation: P. Ducoroy et al., The immunosuppressant LF 15-0195 prevents collagen-induced arthritis with IL-10 down-regulation, TRANSPLAN P, 33(3), 2001, pp. 2142-2145
Authors:
Ducoroy, P
de Fornel, D
Chirade, F
Fontet, P
Dutartre, P
Citation: P. Ducoroy et al., The immunosuppressant LF-150195 inhibits the progression of established collagen-induced arthritis by blockage of anticollagen IgG2a production, TRANSPLAN P, 33(3), 2001, pp. 2281-2283
Authors:
Docagne, F
Colloc'h, N
Bougueret, V
Page, M
Paput, J
Tripier, M
Dutartre, P
MacKenzie, ET
Buisson, A
Komesli, S
Vivien, D
Citation: F. Docagne et al., A soluble transforming growth factor-beta (TGF-beta) type I receptor mimics TGF-beta responses, J BIOL CHEM, 276(49), 2001, pp. 46243-46250
Citation: S. Komesli et al., Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues, INT J IMMUN, 21(5), 1999, pp. 349-358
Authors:
Lebreton, L
Jost, E
Carboni, B
Annat, J
Vaultier, M
Dutartre, P
Renaut, P
Citation: L. Lebreton et al., Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 2. Structural modifications of the spermidine moiety, J MED CHEM, 42(23), 1999, pp. 4749-4763
Authors:
Lebreton, L
Annat, J
Derrepas, P
Dutartre, P
Renaut, P
Citation: L. Lebreton et al., Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 1. Structural modifications of the hydroxyglycine moiety, J MED CHEM, 42(2), 1999, pp. 277-290
Citation: J. Annat et P. Dutartre, T cell repertoire expression in murine recipients of bone marrow transplant after LF 08-0299 (Tresperimus) administration, TRANSPL IMM, 6(4), 1998, pp. 217-224